These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 1013675)

  • 1. [Hemodynamic changes under metoprolol compared to propranolol in hypertensive patients].
    Pfisterer M; Burkart F; Bühler FR; Schweizer W
    Schweiz Med Wochenschr; 1976 Nov; 106(45):1567-9. PubMed ID: 1013675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metoprolol in high renin hypertension. A comparison with propranolol.
    Lameyer LD; Hesse CJ
    Ann Clin Res; 1981; 13 Suppl 30():16-22. PubMed ID: 7027889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hemodynamic changes in patients with arterial hypertension after beta-receptor blockade with propranolol and metoprolol (author's transl)].
    Isbary J; Greding H; Nechwatal W; König E
    Z Kardiol; 1978 Dec; 67(12):857-62. PubMed ID: 735294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic and plasma renin effects of propranolol in essential hypertension.
    Mookherjee S; Eich RH; Obeid AI; Smulyan H
    Arch Intern Med; 1977 Mar; 137(3):290-5. PubMed ID: 843147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies with a new cardioselective beta-blocker, metoprolol.
    Werkö L; Aurell M; Johnsson G; Sannerstedt R; Svedmyr N
    Adv Clin Pharmacol; 1976; 11():19-25. PubMed ID: 1032569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-adrenoceptor stimulating and blocking agents in essential hypertension: single and combined therapy with terbutaline and metoprolol.
    Schulte KL; Meyer-Sabellek W; Thiede HM; Röcker L; Gotzen R
    Int J Clin Pharmacol Ther Toxicol; 1987 Oct; 25(10):539-44. PubMed ID: 3323072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of acute beta-adrenoceptor blockage (metoprolol i.v.) on plasma norepinephrine concentration and hemodynamics in postmyocardial infarction patients].
    Delius W; Wirtzfeld A; Dominiak P; Sebening H; Blömer H; Grobecker H
    Z Kardiol; 1979 Jul; 68(7):441-8. PubMed ID: 473845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of acute cardioselective and non-selective beta-adrenergic blockade on left-ventricular volumes and vascular resistance at rest and during exercise.
    Kelbaek H; Godtrfedsen J
    Scand J Clin Lab Invest; 1991 Apr; 51(2):161-6. PubMed ID: 1675022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metoprolol and propranolol in the treatment of essential hypertension - a long-term comparative study.
    Sjöberg KH
    Ann Clin Res; 1981; 13 Suppl 30():23-9. PubMed ID: 7027890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Exercise hemodynamics and renin before and after acute beta block in patients with essential hypertension].
    Burkart F; Bühler FR; Pfisterer M; Küng M
    Schweiz Med Wochenschr; 1976 Dec; 106(49):1732-5. PubMed ID: 13488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
    Man in't Veld AJ; Schalekamp MA
    Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular hypertrophy regression in hypertensive patients treated with metoprolol.
    Corea L; Bentivoglio M; Verdecchia P; Provvidenza M; Motolese M
    Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):365-70. PubMed ID: 6236155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antihypertensive treatment with metoprolol: haemodynamic reactions in hypertensives with normal left ventricular function (author's transl)].
    Patyna WD
    Dtsch Med Wochenschr; 1982 Apr; 107(15):584-7. PubMed ID: 7067639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renin and beta-blockade: prorenin and aldosterone may explain the controversy.
    McKenna F; Davison AM
    Clin Nephrol; 1986 Mar; 25(3):149-54. PubMed ID: 2869848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrasting renal haemodynamic responses to the angiotensin converting enzyme inhibitor enalapril and the beta-adrenergic antagonist metoprolol in essential hypertension.
    O'Connor DT; Mosley CA; Cervenka J; Bernstein KN
    J Hypertens Suppl; 1984 Dec; 2(2):S89-92. PubMed ID: 6100882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atenolol in hypertension: follow-up of patients crossed over to this agent from propranolol, pindolol or metoprolol.
    Frewin DB; Penhall RK; Leonello PP; Clapp RJ
    N Z Med J; 1980 Nov; 92(672):389-90. PubMed ID: 6937768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hemodynamic and biological effects of bromocriptine in essential hypertension].
    Allain H; Daubert JC; Massart C; van den Driessche J; Gouffault J
    Arch Mal Coeur Vaiss; 1982 Sep; 75(9):951-62. PubMed ID: 6816179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term reduction of peripheral resistance with celiprolol and effects on left ventricular mass.
    Trimarco B; Lembo G; DeLuca N; Ricciardelli B; Rosiello G; Volpe M; Orofino G; Condorelli M
    J Int Med Res; 1988; 16 Suppl 1():62A-72A. PubMed ID: 2906018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prorenin and beta-blockade in hypertension.
    McKenna F; Davison AM
    Proc Eur Dial Transplant Assoc; 1983; 20():566-71. PubMed ID: 6140678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic and adrenergic responses of bevantolol and propranolol in hypertensives.
    Snedden W; Fernandez PG; Vasdev S; Bolli P
    Can J Cardiol; 1989; 5(1):37-41. PubMed ID: 2563955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.